Edema Clinical Trials

8 recruiting

Edema Trials at a Glance

236 actively recruiting trials for edema are listed on ClinicalTrialsFinder across 6 cities in 58 countries. The largest study group is Not Applicable with 89 trials, with the heaviest enrollment activity in St Louis, New York, and Cincinnati. Lead sponsors running edema studies include Universitaire Ziekenhuizen KU Leuven, Dalarna County Council, Sweden, and Abramson Cancer Center at Penn Medicine.

Treatments under study

About Edema Clinical Trials

Looking for clinical trials for Edema? There are currently 8 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Edema trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Edema clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 236 trials

Recruiting
Not Applicable

ILR to Prevent BRCL_MCC 23608

Breast Cancer Lymphedema
University of South Florida98 enrolled3 locationsNCT07127003
Recruiting
Phase 2

A Study to Test Whether BI 1815368 Helps People With an Eye Condition Called Diabetic Macular Edema

Macular Edema
Boehringer Ingelheim300 enrolled80 locationsNCT06962839
Recruiting
Phase 2

Safety, Tolerability and Efficacy of Intravitreal KIO-104 in Patients With Macular Edema

Macular Edema
Kiora Pharmaceuticals, Inc.28 enrolled4 locationsNCT06825702
Recruiting

Measuring Fluid Buildup in Cancer Patients

OedemaChemotherapyCancer+4 more
Jens Rikardt Andersen46 enrolled1 locationNCT07443618
Recruiting
Phase 3

Clinical Study to Compare Efficacy and Safety of AVT29 and Eylea HD in Participants With Diabetic Macular Edema

Diabetic Macular Edema
Alvotech Swiss AG256 enrolled1 locationNCT07489131
Recruiting
Phase 3

Phase 3 Extension Study of ADX-324 in Participants With Hereditary Angioedema (HAE)

Hereditary Angioedema (HAE)Hereditary Angioedema - Type 1Hereditary Angioedema - Type 2+1 more
ADARx Pharmaceuticals, Inc.90 enrolled48 locationsNCT07428499
Recruiting
Phase 3

Donidalorsen Treatment in Children With Hereditary Angioedema

Hereditary Angioedema (HAE)
Ionis Pharmaceuticals, Inc.20 enrolled6 locationsNCT07298447
Recruiting

Validation and Clinical Utility of the Lung Sliding Index (LSI) for Differentiating Pulmonary Diseases

PneumothoraxCOPDPneumonia+4 more
Assiut University700 enrolled1 locationNCT06983366
Recruiting
Phase 1

A Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of RO7823653 in Participants With Diabetic Macular Edema (DME)

Diabetic Macular Edema
Genentech, Inc.93 enrolled8 locationsNCT07425522
Recruiting
Phase 3

STOP-HAE: A Phase 3 Study of ADX-324 in HAE

Hereditary AngioedemaHereditary Angioedema - Type 1Hereditary Angioedema - Type 2+1 more
ADARx Pharmaceuticals, Inc.90 enrolled50 locationsNCT06960213
Recruiting
Phase 4

Optimized Treatment of Pulmonary Edema or Congestion

Congestive Heart FailurePulmonary EdemaAcute Heart Failure
Rigshospitalet, Denmark1,104 enrolled4 locationsNCT05276219
Recruiting

DATA-INSIGHT is a Project That Looks at Health Data in Germany to Find Out How Many Patients Suffer From Eye Disease. The Project Also Explores New Ways to Collect and Use Publicly Available Healthcare Information.

Neovascular Age-related Macular Degeneration (nAMD); Diabetic Macular Edema (DME); Retinal Vein Occlusion (RVO)
Bayer50,000 enrolled1 locationNCT07308639
Recruiting

A Real-World Study to Gain Clinical Insights Into Faricimab (FaReal Study)

Neovascular Age-related Macular DegenerationDiabetic Macular Edema
Hoffmann-La Roche850 enrolled59 locationsNCT06680817
Recruiting
Phase 3

A Study of Navenibart in Participants With Hereditary Angioedema

Hereditary Angioedema (HAE)
Astria Therapeutics, Inc.145 enrolled85 locationsNCT06842823
Recruiting
Phase 3

AURN001 Efficacy in Participants With Corneal Edema Secondary to Corneal Endothelial Dysfunction

Corneal EdemaCorneal Endothelial DysfunctionFuchs Endothelial Corneal Dysfunction+1 more
Aurion Biotech120 enrolled12 locationsNCT07368959
Recruiting
Not Applicable

Video Intervention to Improve Understanding of Diabetic Retinopathy at Zuckerberg San Francisco General Hospital and Trauma Center

Diabetic Retinopathy (DR)Macular Edema (ME)
University of California, San Francisco150 enrolled1 locationNCT07519707
Recruiting
Not Applicable

Plasma Rich in Growth Factors in Corneal Endothelial Transplantation

Fuchs' Endothelial DystrophyCorneal Edema
University of Miami100 enrolled2 locationsNCT06261346
Recruiting
Not Applicable

Biomarkers in Diabetic Retinopathy Treated With Faricimab vs Biosimilar Ranibizumab

Diabetic Retinopathy (DR)Diabetic Macular Edema (DME)
Osijek University Hospital100 enrolled1 locationNCT07520045
Recruiting
Phase 2

Comparison of Submucosal Dexamethasone and Methylprednisolone in Postoperative Sequelae of Parasymphsis Fractures

Pain ManagementMandible FractureCorticosteroid Injection+1 more
Nishtar Medical University72 enrolled1 locationNCT07208799
Recruiting
Phase 3

COMO: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME

Diabetic Macular Edema (DME)Diabetic Macular EdemaDME
EyePoint Pharmaceuticals, Inc.240 enrolled39 locationsNCT07449936